文献速递消化内镜消化道肿瘤与早癌

三维成像设备对结肠镜检查中息肉和腺瘤检出效果的影响:一项随机对照试验

Effect of 3-Dimensional Imaging Device on Polyp and Adenoma Detection During Colonoscopy: A Randomized Controlled Trial.
PubMed 文献 · Am J Gastroenterol · 2023-07-07

这项单盲随机对照试验纳入1196名18-70岁接受诊断或筛查性结肠镜检查的参与者,按1:1随机分为2D-3D组和3D-2D组。第一阶段2D与3D组的息肉检出率(PDR)和腺瘤检出率(ADR)无显著差异;第二阶段3D组PDR和ADR显著高于2D组。亚组分析显示3D组在中间水平和初级内镜医师中PDR和ADR显著更高。

要点

  • 第二阶段3D组PDR为27.7%,显著高于2D组的19.9%(OR=1.54,95%CI 1.17-2.02,P=0.002)。
  • 第二阶段3D组ADR为13.8%,显著高于2D组的9.9%(OR=1.45,95%CI 1.01-2.08,P=0.041)。
  • 亚组分析显示3D组在中间水平和初级内镜医师中PDR和ADR显著更高。

核心结论

  • 3D成像设备可提高结肠镜检查的总体PDR和ADR,尤其在中间水平和初级内镜医师中。

研究设计与样本

  • 单盲随机对照试验,2019年8月至2022年5月连续纳入18-70岁接受诊断或筛查性结肠镜检查的参与者。
  • 参与者按1:1随机分为2D-3D结肠镜组或3D-2D结肠镜组,采用计算机生成的随机数字。
  • 最终纳入2D-3D组571例和3D-2D组583例,共1196例参与者被招募,排除符合排除标准者后纳入分析。
  • 主要分析为意向性治疗分析。
  • 主要结局包括PDR和ADR,定义为结肠镜检查中检出至少1个息肉或腺瘤的个体比例。

主要发现

  • 第一阶段2D组与3D组PDR分别为39.6%和40.5%(OR=0.96,95%CI 0.76-1.22,P=0.801)。
  • 第二阶段3D组PDR为27.7%,显著高于2D组的19.9%(OR=1.54,95%CI 1.17-2.02,P=0.002)。
  • 第一阶段2D组与3D组ADR分别为24.7%和23.8%(OR=1.05,95%CI 0.80-1.37,P=0.788)。
  • 第二阶段3D组ADR为13.8%,显著高于2D组的9.9%(OR=1.45,95%CI 1.01-2.08,P=0.041)。
  • 亚组分析证实第二阶段3D组PDR和ADR显著更高,尤其在中间水平和初级内镜医师中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To evaluate the effect of 3-dimensional (3D) imaging device on polyp and adenoma detection during colonoscopy. METHODS: In a single-blind, randomized controlled trial, participants aged 18-70 years who underwent diagnostic or screening colonoscopy were consecutively enrolled between August 2019 and May 2022. Each participant was randomized in a 1:1 ratio to undergo either 2-dimensional (2D-3D) colonoscopy or 3D-2D colonoscopy through computer-generated random numbers. Primary outcome included polyp detection rate (PDR) and adenoma detection rate (ADR), defined as the proportion of individuals with at least 1 polyp or adenoma detected during colonoscopy. The primary analysis was intention-to-treat. RESULTS: Of 1,196 participants recruited, 571 in 2D-3D group and 583 in 3D-2D group were finally included after excluding those who met the exclusion criteria. The PDR between 2D and 3D groups was separately 39.6% and 40.5% during phase 1 (odds ratio [OR] = 0.96, 95% confidence interval [CI]: 0.76-1.22, P = 0.801), whereas PDR was significantly higher in 3D group (27.7%) than that of 2D group (19.9%) during phase 2, with a 1.54-fold increase (1.17-2.02, P = 0.002). Similarly, the ADR during phase 1 between 2D (24.7%) and 3D (23.8%) groups was not significant (OR = 1.05, 0.80-1.37, P = 0.788), while ADR was significantly higher in 3D group (13.8%) than that of 2D group (9.9%) during phase 2, with a 1.45-fold increase (1.01-2.08, P = 0.041). Further subgroup analysis confirmed significantly higher PDR and ADR of 3D group during phase 2, particularly in midlevel and junior endoscopists. DISCUSSION: The 3D imaging device could improve overall PDR and ADR during colonoscopy, particularly in midlevel and junior endoscopists. Trial number: ChiCTR1900025000.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Sun X, Zhang Q, Wu S, et al. Effect of 3-Dimensional Imaging Device on Polyp and Adenoma Detection During Colonoscopy: A Randomized Controlled Trial. Am J Gastroenterol. 2023. PMID: 37410933. doi:10.14309/ajg.0000000000002396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。